RPRX financials
Royalty Pharma (RPRX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RPRX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $2.38B | $2.38B | $1.56B | $770.95M | 1.80 |
| 2024 | $2.26B | $2.26B | $1.29B | $858.98M | 1.91 |
| 2023 | $2.35B | $2.35B | $1.49B | $1.13B | 2.53 |
| 2022 | $2.24B | $2.24B | $307.06M | $42.83M | 0.10 |
| 2021 | $2.29B | $2.29B | $1.43B | $619.73M | 1.49 |
| 2020 | $2.12B | $2.12B | $1.60B | $975.04M | 1.28 |
- RPRX revenue was $2.38B in fiscal 2025, net income $770.95M.
Updated 2026-11-03 02:02 UTC